title: Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop.
authors.affiliation: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: James P
authors.initials: JP
authors.lastname: Stables
authors.forename: Ed
authors.initials: E
authors.lastname: Bertram
authors.forename: F E
authors.initials: FE
authors.lastname: Dudek
authors.forename: Greg
authors.initials: G
authors.lastname: Holmes
authors.forename: Gary
authors.initials: G
authors.lastname: Mathern
authors.forename: Asla
authors.initials: A
authors.lastname: Pitkanen
authors.forename: H S
authors.initials: HS
authors.lastname: White
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D002908:Chronic Disease; D004195:Disease Models, Animal; D004351:Drug Resistance; D004827:Epilepsy / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D009316:National Institutes of Health (U.S.); D013226:Status Epilepticus / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D014481:United States
chemical_list: D000927:Anticonvulsants